Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Censavudine by Transposon Therapeutics for Amyotrophic Lateral Sclerosis: Likelihood of Approval
Censavudine is under clinical development by Transposon Therapeutics and currently in Phase II for Amyotrophic Lateral Sclerosis. According to GlobalData,...
Censavudine by Transposon Therapeutics for Frontotemporal Dementia (FTD): Likelihood of Approval
Censavudine is under clinical development by Transposon Therapeutics and currently in Phase II for Frontotemporal Dementia (FTD). According to GlobalData,...
Censavudine by Transposon Therapeutics for Progressive Supranuclear Palsy: Likelihood of Approval
Censavudine is under clinical development by Transposon Therapeutics and currently in Phase II for Progressive Supranuclear Palsy. According to GlobalData,...